Through co-clinical trials at the College of Veterinary Medicine and Weill Cornell Medical College we are learning things that you can't learn from a single organism alone. Information about shared mutations might help predict and identify responses to drugs by comparing across species. It's a win-win situation for both dogs and humans because both will benefit from the research in areas such as lymphoma.